Image 1
Lansoprazole Capsule, Delayed Release
Product Images NDC 0093-7350
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 0093-7350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
This is a chart or table that shows the mean severity of night heartburn for evaluable patients. The severity is measured from 0 to 3, where 0 means none, 1 is mild, 2 is moderate, and 3 is severe. The chart compares the severity of night heartburn for patients taking a placebo, patients taking 15 mg QD of Lansoprazole, and patients taking 30 mg QD of Lansoprazole at different times from the start of treatment, from 5 to 56 days.*
Image 4
This is a code for a package of Lansoprazole delayed-release capsules with a total of 30 capsules. The code is © 95-0552-5600 and the product information cannot be deemed available from the provided text.*
Image 5
This appears to be a label of a medication called "Lansoprazole Delayed-Release Capsules, USP". It comes in a bottle containing 30 capsules. The phone number "95-1551-5600" and reference number "NoC0053 735155" are also included.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
